Skip to content
777 Sourcing.

Capability

precision oncology

Suppliers
2
States & provinces
2
Countries
1

2 precision oncology suppliers across 2 states and provinces in 1 country. Profiles show capabilities, materials, certifications, and facility locations so you can compare shops and build a shortlist.

Suppliers

BECTAS THERAPEUTICS, INC.

HOUSTON, TX

Bectas Therapeutics is a preclinical-stage biotech company developing monoclonal antibody therapies for cancer, accompanied by biomarkers to identify patients who will most benefit from each therapeutic antibody. Its programs combine monoclonal antibodies targeting secondary immune checkpoints that regulate myeloid-dependent immune suppression with patient-selection biomarkers based on insights from human patients. The company was awarded a $2.75M product development seed grant from the Cancer Prevention Research Institute of Texas (CPRIT) to support pre

biomarker developmentmonoclonal antibody developmentpre-clinical development

Compiled from public sources

KURA ONCOLOGY, INC

SAN DIEGO, CA

Kura Oncology, Inc. is a biopharmaceutical company that discovers and develops novel cancer therapeutics, aiming to realize the promise of precision medicines to help patients with cancer lead better, longer lives. Its therapies are designed to selectively target cancer cells, and it investigates them in combination with standards of care. It focuses on areas including head and neck cancer, lung cancer and acute leukemias.

clinical developmentdrug developmentdrug discovery

Compiled from public sources

Related capabilities

Other processes offered by the shops that list precision oncology.

Browse all capabilities